News|Articles| June 4, 2026
The Peptide Reclassification Everyone’s Talking About: A Pharmacist’s Take on What RFK Jr’s Announcement Actually Means
Key Takeaways
The Department of Health and Human Services indicated BPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin, and others may return to Category 1, while melanotan II, GHRP-2/6, LL-37, and PEG-MGF likely will remain restricted.Reclassification governs compounding legality only; it does not confer FDA approval, validated indications, standardized dosing, or established benefit–risk, because phase 1-3 evidence and new drug application/biologics license application review are absent.
Please read this disclaimer before continuingThis document is provided strictly for educational and informational purposes related to laboratory research. The compounds referenced within this material are research chemicals intended for laboratory research use only and are not approved for human or veterinary consumption. The information contained in this document does not constitute medical advice, treatment recommendations, or dosing guidance for humans or animals. Any protocols, dosing schedules, or procedures described are derived from published or investigational research models and are presented solely for the purpose of scientific reference and discussion. Many compounds referenced in this document are investigational substances that have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease. Their safety and efficacy outside of controlled research settings have not been established. This material is not intended to promote or encourage human use of any investigational compound. Individuals should not interpret the information contained herein as instructions for personal use or as a substitute for professional medical advice. Medical decisions should always be made in consultation with a qualified and licensed healthcare professional. By accessing or using this document, the reader acknowledges that the information is provided for research and educational reference only and agrees to assume full responsibility for the legal, ethical, and appropriate use of the information presented. The author and distributor of this document disclaim any liability for misuse, misinterpretation, or application of the information outside of legitimate research contexts